ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Herceptin drops on contracting ahead of U.S. biosim, but Roche sales stomp anyway
Biosimilars to Roche’s top-selling cancer drugs Herceptin and Avastin entered the U.S. last week. But thanks to PD-L1 inhibitor Tecentriq, hemophilia drug Hemlibra and multiple sclerosis therapy Ocrevus, Roche is still counting on sales growth this year.
Pharma Sources Insight January 2025
